Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Ottani

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Revista Espanola De Cardiologia (English Ed.)|April 25, 2026
Beta-blockers after invasively managed STEMI vs NSTEMI without reduced ejection fraction: a prespecified analysis from the REBOOT trialSergio Raposeiras-Roubín, Manuel Anguita, Roberto Latini, et al.
International Journal of Cardiology|July 30, 2022
Impact of hemoglobin levels at admission on outcomes among elderly patients with acute coronary syndrome treated with low-dose Prasugrel or clopidogrel: A sub-study of the ELDERLY ACS 2 trialGiuseppe De Luca, Monica Verdoia, Nuccia Morici, et al.
American Heart Journal|November 6, 2024
Transcatheter aortic-valve implantation with or without on-site cardiac surgery: The TRACS trialGianmarco Iannopollo, Marta Cocco, Alessandro Leone, et al.
Circulation|February 21, 2018
Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients With Acute Coronary Syndromes Undergoing Early Percutaneous RevascularizationStefano Savonitto, Luca A Ferri, Luigi Piatti, et al.
The New England Journal of Medicine|September 1, 2025
Beta-Blockers after Myocardial Infarction without Reduced Ejection FractionBorja Ibanez, Roberto Latini, Xavier Rossello, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Revista Espanola De Cardiologia (English Ed.)|April 25, 2026
Beta-blockers after invasively managed STEMI vs NSTEMI without reduced ejection fraction: a prespecified analysis from the REBOOT trialSergio Raposeiras-Roubín, Manuel Anguita, Roberto Latini, et al.
International Journal of Cardiology|July 30, 2022
Impact of hemoglobin levels at admission on outcomes among elderly patients with acute coronary syndrome treated with low-dose Prasugrel or clopidogrel: A sub-study of the ELDERLY ACS 2 trialGiuseppe De Luca, Monica Verdoia, Nuccia Morici, et al.
American Heart Journal|November 6, 2024
Transcatheter aortic-valve implantation with or without on-site cardiac surgery: The TRACS trialGianmarco Iannopollo, Marta Cocco, Alessandro Leone, et al.
Circulation|February 21, 2018
Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients With Acute Coronary Syndromes Undergoing Early Percutaneous RevascularizationStefano Savonitto, Luca A Ferri, Luigi Piatti, et al.
The New England Journal of Medicine|September 1, 2025
Beta-Blockers after Myocardial Infarction without Reduced Ejection FractionBorja Ibanez, Roberto Latini, Xavier Rossello, et al.
Pageof 8